V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010506 | 310004414 | 0 | 83.4 | Adjuvant (A) | 2014-07-20 | 2014-07-27 | null | 02 | N | 310017276 | NOT MATCHED |
| 310010507 | 310004419 | 1.67 | null | Curative (C) | 2019-04-25 | 2019-05-05 | IVE | 02 | N | 310017284 | IVE |
| 310010509 | 310009695 | 1.4 | 59.1 | Curative (C) | 2018-01-20 | 2018-01-21 | PEMBROLIZUMAB | 02 | N | 310017348 | PEMBROLIZUMAB |
| 310010510 | 310011541 | 1.57 | 95 | null | null | 2017-02-07 | Gemcitabine day 1&8 | N | N | 310017383 | GEMCITABINE |
| 310010511 | 310004437 | 1.51 | 60.85 | Palliative (P) | 2016-08-25 | 2016-12-23 | Carboplatin + Liposomal Doxorubicin | N | N | 310017385 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010512 | 310010676 | 1.55 | 57 | Palliative (P) | 2016-11-06 | 2016-11-06 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310017421 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010513 | 310004444 | 1.66 | 53.5 | Palliative (P) | 2016-03-20 | 2016-03-21 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310017432 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010514 | 310004447 | null | 55.3 | Curative (C) | 2016-11-09 | 2016-11-16 | BEAM | 2 | N | 310017474 | BEAM |
| 310010515 | 310007873 | 1.62 | 14.8 | Curative (C) | 2016-07-10 | 2016-07-10 | PEMBROLIZUMAB | 02 | N | 310017503 | PEMBROLIZUMAB |
| 310010516 | 310004457 | null | 63 | Palliative (P) | 2018-05-06 | 2018-05-26 | PEMBROLIZUMAB | 02 | N | 310017513 | PEMBROLIZUMAB |
| 310010517 | 310004460 | 1.77 | 94.3 | Curative (C) | null | 2013-11-12 | LEAM | 02 | N | 310017518 | LEAM |
| 310010518 | 310004465 | null | 62.2 | Palliative (P) | 2018-03-31 | 2018-04-06 | PEMBROLIZUMAB | 02 | N | 310017575 | PEMBROLIZUMAB |
| 310010519 | 310004474 | 1.66 | 165.7 | Palliative (P) | 2019-08-18 | 2019-08-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310017644 | CISPLATIN + GEMCITABINE |
| 310010520 | 310004482 | 1.78 | null | Curative (C) | 2017-11-19 | 2017-11-26 | GEM-P | 02 | null | 310017721 | GEMCITABINE + PACLITAXEL |
| 310010521 | 310004489 | 1.74 | 69 | null | 2019-04-02 | 2019-04-07 | Gemcitabine weekly | N | N | 310017733 | GEMCITABINE |
| 310010522 | 310004491 | 1.63 | 74.7 | Curative (C) | 2018-01-10 | 2018-01-14 | NB HRNBL-1 TVD | N | N | 310017744 | NOT MATCHED |
| 310010523 | 310007905 | 0 | 83 | Curative (C) | 2017-10-27 | 2017-11-08 | Brentuximab | N | Y | 310017864 | BRENTUXIMAB |
| 310010524 | 310004505 | 1.65 | 108.6 | Curative (C) | 2015-04-01 | 2015-12-10 | IVE | 02 | N | 310017871 | IVE |
| 310010526 | 310004512 | null | 93.8 | Curative (C) | 2014-02-09 | 2014-02-18 | NB HRNBL-1 Isotretinoin | N | N | 310017889 | NOT MATCHED |
| 310010527 | 310004514 | 1.19 | 94.3 | Curative (C) | 2015-01-29 | 2015-01-30 | null | 02 | N | 310017898 | NOT MATCHED |
| 310010528 | 310004516 | null | 58.3 | Curative (C) | 2016-12-22 | 2016-12-28 | PEMBROLIZUMAB | N | N | 310017905 | PEMBROLIZUMAB |
| 310010529 | 310004522 | 1.77 | 64 | Curative (C) | 2015-01-01 | 2015-01-22 | BEAM | N | N | 310017935 | BEAM |
| 310010530 | 310004525 | 1.76 | 89 | Palliative (P) | 2017-05-13 | 2017-10-30 | Gemcitabine weekly | N | N | 310017972 | GEMCITABINE |
| 310010531 | 310004534 | 1.6 | null | Palliative (P) | 2017-05-03 | 2017-05-16 | GEMCITABINE | N | N | 310018019 | GEMCITABINE |
| 310010532 | 310004537 | 1.78 | 81.7 | Curative (C) | 2017-08-15 | 2018-03-04 | IVE | N | N | 310018037 | IVE |
| 310010533 | 310004541 | 1.68 | 57.8 | Disease modification (D) | 2018-04-01 | 2018-06-03 | Bexarotene | 2 | N | 310018046 | UKALL2011 |
| 310010534 | 310004547 | 1.62 | 60.7 | Palliative (P) | 2016-05-31 | 2016-06-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310018070 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310010535 | 310004548 | 1.77 | 77.5 | Palliative (P) | 2018-01-14 | 2018-02-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 310018083 | BEXAROTENE |
| 310010537 | 310004552 | 1.7 | null | Palliative (P) | 2017-10-17 | 2017-10-23 | Rituximab | 02 | N | 310018091 | RITUXIMAB |
| 310010538 | 310007933 | 1.89 | null | Disease modification (D) | 2015-04-01 | 2015-05-17 | Ipilimumab | 02 | null | 310018115 | IPILIMUMAB |
| 310010539 | 310004559 | 1.66 | 65.6 | Palliative (P) | 2016-08-07 | 2016-09-10 | Etoposide oral | N | N | 310018121 | ETOPOSIDE |
| 310010540 | 310004563 | 1.66 | 78 | Curative (C) | 2017-01-20 | 2017-03-31 | Etoposide oral | 02 | null | 310018127 | ETOPOSIDE |
| 310010541 | 310004570 | 1.36 | 100.4 | Palliative (P) | 2015-01-23 | 2015-01-25 | Rituximab | 2 | N | 310018158 | RITUXIMAB |
| 310010542 | 310004572 | 1.82 | 90.5 | Palliative (P) | 2014-06-12 | 2015-10-24 | Etoposide oral | null | N | 310018180 | ETOPOSIDE |
| 310010543 | 310004581 | 1.66 | null | Palliative (P) | 2018-09-12 | 2018-09-12 | Bexarotene | 02 | N | 310018236 | UKALL2011 |
| 310010544 | 310004582 | null | 79.2 | Disease modification (D) | 2019-05-23 | 2019-05-23 | Rituximab | N | N | 310018245 | RITUXIMAB |
| 310010545 | 310004587 | null | 75 | Curative (C) | 2015-02-18 | 2016-04-19 | ESHAP | N | N | 310018276 | UKALL2011 |
| 310010546 | 310004588 | null | 67.3 | Adjuvant (A) | 2015-04-13 | 2015-07-20 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018278 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310010547 | 310007949 | 1.65 | 77.3 | Curative (C) | 2016-04-17 | 2016-04-18 | Ipilimumab | 2 | N | 310018282 | IPILIMUMAB |
| 310010548 | 310010702 | 1.64 | 113.4 | null | 2017-01-01 | 2017-01-01 | Rituximab | 02 | N | 310018292 | RITUXIMAB |
| 310010549 | 310007951 | 1.69 | null | Curative (C) | 2017-04-15 | 2018-02-05 | Methotrexate intrathecal | N | N | 310018298 | METHOTREXATE INTRATHECAL |
| 310010550 | 310004597 | 1.78 | null | Palliative (P) | 2015-07-24 | 2015-08-22 | Rituximab | N | N | 310018316 | RITUXIMAB |
| 310010551 | 310004600 | 1.7 | 29.6 | Adjuvant (A) | 2014-06-07 | 2014-07-05 | GDP | 02 | N | 310018317 | GDP |
| 310010552 | 310007956 | null | 57.8 | null | 2017-01-07 | 2017-04-16 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018342 | UKALL2011 |
| 310010553 | 310011251 | 1.59 | 82.3 | Curative (C) | null | 2016-06-08 | GDP | 02 | N | 310018365 | GDP |
| 310010554 | 310004615 | 1.83 | null | Palliative (P) | 2018-02-15 | 2018-02-21 | Bexarotene | 2 | N | 310018370 | CARBOPLATIN + ETOPOSIDE |
| 310010555 | 310009750 | 1.73 | 84.6 | Not known (9) | 2017-12-09 | 2018-02-24 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018444 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310010556 | 310007965 | 1.75 | 52 | null | null | 2018-04-10 | Ipilimumab | N | N | 310018446 | IPILIMUMAB |
| 310010557 | 310007967 | 1.71 | 56.8 | Curative (C) | 2014-11-10 | 2014-11-14 | Methotrexate Intrathecal (any age) | 2 | N | 310018458 | METHOTREXATE INTRATHECAL |
| 310010558 | 310007969 | null | 95.7 | null | 2015-07-13 | 2015-09-30 | Ipilimumab | 2 | N | 310018464 | IPILIMUMAB |